The study is testing the company's Sophia DDM platform for assessing the response of lung cancer patients to immunotherapy through tracking multimodal signatures. Sophia DDM offers data visualization, cohorting, and predictive tools, the company said. The study includes 19 sites in seven countries; to date, 500 patients have been recruited to participate.
The company has also inked an agreement with GE Healthcare to use that firm's Imaging Fabric Core and Imaging Fabric Annotation template, both of which are part of GE's Edison Digital Health platform. Sophia will use GE's Imaging Fabric services in the DEEP-Lung-IV study for medical imaging and annotation, it said.
Copyright © 2022 AuntMinnie.com